The global mycoplasma testing market is projected to grow at a robust 11% CAGR from 2022 to 2027. Key drivers include ...
Urban areas face unprecedented challenges due to climate change, biodiversity loss, and rapid population growth. In this ...
SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or ...
All-stock acquisition includes clinical-stage CD19/BCMA Dual-CAR T programAcquisition will expand existing advanced ...
(NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs ...
CF602 is a novel A3AR allosteric modulator that enhances the receptor activity in the presence of the native ligand. The molecule is characterized by high selectivity at the A3AR and is capable of ...
Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biopharmaceutical company developing therapeutics using ...
Pharmaceutical Technology on MSN
New protein manufacturing technologies likely to play key role in “five to ten years”
Eleva’s CEO says CHO cell line alternatives could become common as large molecule drugs become complex and harder to produce ...
Every year, the fields of fisheries and aquaculture generate substantial quantities of leftover biomass, including heads, ...
Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biopharmaceutical company developing therapeutics using its proprietary ...
The Chosun Ilbo on MSN
Samsung Electronics Names Roh Tae-moon CEO in Smaller Reshuffle
Samsung Electronics announced its 2026 regular executive vice president appointments on the 21st, involving a total of four ...
Artiva remains on track to share initial clinical response data and conduct U.S. Food and Drug Administration (FDA) regulatory interactions to align on pivotal trial design for AlloNK in refractory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback